Healthcare - Biotechnology - NASDAQ - US
$ 8.23
-2.72 %
$ 301 M
Market Cap
-2.9
P/E
Price Target
Average
357.68%
Revenue Forecast
Estimate
115.78%
EBIT
Estimate
29.70%
Net Income
Estimate
61.05%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
iTeos Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for ITOS of $37.7 , with forecasts ranging from a low of $31 to a high of $46 .
ITOS Lowest Price Target
Wall Street Target
31 USD
276.67%
ITOS Average Price Target
Wall Street Target
37.7 USD
357.68%
ITOS Highest Price Target
Wall Street Target
46 USD
458.93%
REVENUE FORECAST
Revenue Forecast Chart ITOS
EBIT FORECAST
EBIT Forecast Chart ITOS
NET INCOME FORECAST
Net Income Chart ITOS